Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127217) titled 'A Multicenter, Randomized, Crossover, Placebo-Controlled, Superiority Clinical Trial Protocol to Evaluate the Efficacy and Safety of cellulose enhancing capsules' on June 26.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Shanghai Tenth People's Hospital
Condition:
Overweight and Obesity
Intervention:
Experimental group:receives a cellulose enhancing capsules (composed of cross-linked hydrogel particles and a gelatin capsule shell)
Recruitment Status: Not Recruiting
Phase: 3
Date of First Enrollment: 2025-05-15
Target Sample Size: Experimental group:90;Control group:90;
Co...